We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
VITRAKVI larotrectinib (as sulfate) 20 mg/mL bottle, Bayer Australia Ltd, CON-1097
Product name
VITRAKVI larotrectinib (as sulfate) 20 mg/mL bottle
Sponsor name
Bayer Australia Ltd
Consent start
Consent no.
CON-1097
Duration
The consent is effective from 21 April 2023 until 30 April 2025.
Standard
Paragraph 8(1)(o) of Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines
Non-compliance with standard
The product does not have the name of the medicine printed on the top or bottom
panel, meaning it is not on three opposing sides
Import, Supply, &/or Export
import and supply
Therapeutic product type
Prescription medicines